Thermo Fisher Scientific Stock Today
| TMO Stock | USD 529.63 7.97 1.53% |
Performance0 of 100
| Odds Of DistressLess than 3
|
Thermo Fisher is selling at 529.63 as of the 30th of November 2024; that is 1.53 percent increase since the beginning of the trading day. The stock's open price was 521.66. Thermo Fisher has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Thermo Fisher Scientific's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 13th of January 1978 | Category Healthcare | Classification Health Care |
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company was incorporated in 1956 and is based in Waltham, Massachusetts. Thermo Fisher operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. The company has 382.5 M outstanding shares of which 3.23 M shares are at this time shorted by investors with about 2.12 days to cover. More on Thermo Fisher Scientific
Moving together with Thermo Stock
| 0.73 | A | Agilent Technologies Sell-off Trend | PairCorr |
| 0.92 | ME | 23Andme Holding Upward Rally | PairCorr |
| 0.81 | VALN | Valneva SE ADR | PairCorr |
Moving against Thermo Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Thermo Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Marc Casper | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, ARCA Institutional, SP 100, SP 100 Index, Measuring and Control Equipment, ESG Investing, Macroaxis Picks, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal TestingCatholic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsThermo Fisher can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Thermo Fisher's financial leverage. It provides some insight into what part of Thermo Fisher's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thermo Fisher Scientific (TMO) is traded on New York Stock Exchange in USA. It is located in 168 Third Avenue, Waltham, MA, United States, 02451 and employs 122,000 people. Thermo Fisher is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 202.58 B. Thermo Fisher Scientific runs under Life Sciences Tools & Services sector within Health Care industry. The entity has 382.5 M outstanding shares of which 3.23 M shares are at this time shorted by investors with about 2.12 days to cover.
Thermo Fisher Scientific has about 8.52 B in cash with 8.41 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.44.
Check Thermo Fisher Probability Of Bankruptcy
Ownership AllocationThermo Fisher Scientific shows a total of 382.5 Million outstanding shares. The majority of Thermo Fisher Scientific outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Thermo Fisher to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Thermo Fisher Scientific. Please pay attention to any change in the institutional holdings of Thermo Fisher Scientific as this could imply that something significant has changed or is about to change at the company. Please note that on October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Thermo Fisher Scientific's common stock.
Check Thermo Ownership Details
Thermo Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Norges Bank | 2024-06-30 | 5.6 M | |
| Franklin Resources Inc | 2024-09-30 | 5.4 M | |
| Northern Trust Corp | 2024-09-30 | 3.5 M | |
| Massachusetts Financial Services Company | 2024-09-30 | 3.4 M | |
| Royal Bank Of Canada | 2024-06-30 | 3.3 M | |
| Wellington Management Company Llp | 2024-06-30 | 3 M | |
| Legal & General Group Plc | 2024-06-30 | 3 M | |
| Polen Capital | 2024-09-30 | 2.8 M | |
| Bank Of New York Mellon Corp | 2024-06-30 | 2.7 M | |
| Vanguard Group Inc | 2024-09-30 | 33.1 M | |
| Blackrock Inc | 2024-06-30 | 29.5 M |
Thermo Fisher Historical Income Statement
Thermo Stock Against Markets
Thermo Fisher Corporate Directors
| Tyler Jacks | Independent Director | Profile | |
| James Mullen | Independent Director | Profile | |
| Dion Weisler | Independent Director | Profile | |
| Debora Spar | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Dividend Share 1.52 | Earnings Share 15.94 | Revenue Per Share 110.627 | Quarterly Revenue Growth 0.002 |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.